Medicine Atlas

How Healing Is Practiced
Sign In
Text size
100%
Theme
Condition

Floating-Harbor syndrome

Congenital Malformations and Chromosomal Abnormalities

Floating-Harbor syndrome is a rare genetic disorder marked by short stature, delayed bone age, delayed speech development and a characteristic facial appearance. It is named for the two hospitals where it was first described, the Boston Floating Hospital and Harbor General Hospital in Torrance, California. Growth deficiency usually shows in the first year of life, and bone age is delayed in early childhood but is typically normal by age 6 to 12. Speech delay can be severe, and most affected people also have mild intellectual disability. Typical facial features include a triangular face, a low hairline, deep-set eyes, long eyelashes, a distinctive large nose with an overhanging columella, a short philtrum and thin lips. Some people have short, clubbed or curved fingers, a high-pitched voice, or undescended testes in males. It is caused by mutations in the SRCAP gene and inherited in an autosomal dominant pattern, although most cases arise as new mutations. Only about 50 cases have been reported in the medical literature.

Facts
Classification
Body System
Skeletal System 1
Communicable or Non-communicable
Non-Communicable 1
Transmission Route
Non-Transmissible 1
Causative Agent
Causative Agent (category)
Genetic / Hereditary 1
Connections

Treated By

Source National Organization for Rare Disorders (NORD): Floating-Harbor syndrome (NORD Rare Disease Database)
Sources
1. Floating-Harbor syndrome (MedlinePlus Genetics)
  • Description
    slowing of the mineralization of the bones (delayed bone age)
  • Causes
    Floating-Harbor syndrome is caused by mutations in the SRCAP gene.
  • Inheritance
    This condition is inherited in an autosomal dominant pattern
View the Source
National Organization for Rare Disorders (NORD): Floating-Harbor syndrome (NORD Rare Disease Database)
National Organization for Rare Disorders (NORD)Treated By: Hormone Therapy, Treatment
Quote, Treated By: Hormone Therapy, Treatment
Growth hormone (GH) therapy has been used to treat some individuals with FHS.
View the Source
Comments (0)
No comments yet. Be the first to share a thought.
Reader Challenges (0)
No disputes yet. Spotted an error or a better source? Open the first one.